Tolcapone: COMT inhibition for the treatment of Parkinson's disease
- PMID: 9591515
- DOI: 10.1212/wnl.50.5_suppl_5.s1
Tolcapone: COMT inhibition for the treatment of Parkinson's disease
Similar articles
-
[Tolcapone in the management of Parkinson's disease].Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(6):71-8. Zh Nevrol Psikhiatr Im S S Korsakova. 2007. PMID: 18688929 Review. Russian. No abstract available.
-
Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004554. doi: 10.1002/14651858.CD004554.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495119 Free PMC article. Review.
-
The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.Clin Neuropharmacol. 2000 May-Jun;23(3):143-8. doi: 10.1097/00002826-200005000-00003. Clin Neuropharmacol. 2000. PMID: 10895397 Clinical Trial.
-
Catechol-O-methyltransferase inhibitors in Parkinson's disease.Lancet. 1998 Jun 27;351(9120):1965-6. doi: 10.1016/s0140-6736(05)78659-1. Lancet. 1998. PMID: 9654299 No abstract available.
-
First COMT inhibitor approved for Parkinson's disease.Am J Health Syst Pharm. 1998 Mar 15;55(6):524, 526. doi: 10.1093/ajhp/55.6.524. Am J Health Syst Pharm. 1998. PMID: 9544322 No abstract available.
Cited by
-
Voltammetric measurement of catechol-O-methyltransferase inhibitor tolcapone in the pharmaceutical form on the boron-doped diamond electrode.Turk J Chem. 2023 Nov 2;48(1):184-194. doi: 10.55730/1300-0527.3650. eCollection 2024. Turk J Chem. 2023. PMID: 38544890 Free PMC article.
-
The efficacy of homemade tolcapone in the treatment of patients with Parkinsons disease.Exp Ther Med. 2018 Jan;15(1):127-130. doi: 10.3892/etm.2017.5377. Epub 2017 Oct 26. Exp Ther Med. 2018. PMID: 29375679 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous